Hopfner Robert Lorne
Insider CIK 1551966 · PCVX Director · INZY Director, 10% owner · RLYB Director · EVMN Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RLYB Rallybio Corp | M Exercise deriv | 2026-10-12 | 2026-10-14 | 2,062 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | M Exercise deriv | 2026-10-12 | 2026-10-14 | 3,562 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | M Exercise deriv | 2026-10-12 | 2026-10-14 | 9,196 | $0.56 | $5.1K | 0 | SEC↗ |
| RLYB Rallybio Corp | M Exercise | 2026-10-12 | 2026-10-14 | 2,062 | $15.28 | $31.5K | 14,820 | SEC↗ |
| RLYB Rallybio Corp | M Exercise | 2026-10-12 | 2026-10-14 | 3,562 | $2.38 | $8.5K | 12,758 | SEC↗ |
| RLYB Rallybio Corp | M Exercise | 2026-10-12 | 2026-10-14 | 9,196 | $7.60 | $69.9K | 9,196 | SEC↗ |
| EVMN Evommune, Inc. | P Buy | 2025-12-19 | 2025-12-22 | 1,000 | $17.35 | $17.4K | 4,026 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 313,571 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 313,571 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,104,740 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 1,895,260 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,508,575 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 2,582,243 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 3,572,816 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 7,145,647 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 25,790 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion deriv | 2025-11-07 | 2025-11-12 | 7,230,283 | — | $0 | 0 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion | 2025-11-07 | 2025-11-12 | 1,632,441 | — | $0 | 1,632,441 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion | 2025-11-07 | 2025-11-12 | 294,502 | — | $0 | 294,502 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion | 2025-11-07 | 2025-11-12 | 1,441,032 | — | $0 | 1,441,032 | SEC↗ |
| EVMN Evommune, Inc. | C Conversion | 2025-11-07 | 2025-11-12 | 3,026 | — | $0 | 3,026 | SEC↗ |
| INZY Inozyme Pharma, Inc. | U Tender | 2025-07-01 | 2025-07-03 | 1,571,741 | $4.00 | $6.29M | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | U Tender | 2025-07-01 | 2025-07-03 | 2,923,110 | $4.00 | $11.69M | 0 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2025-05-13 | 2025-05-15 | 28,500 | — | $0 | 28,500 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2025-01-02 | 2025-01-06 | 73,571 | $0.70 | $51.5K | 73,571 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 28,000 | — | $0 | 28,000 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2024-05-15 | 2024-05-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2023-08-01 | 2023-08-03 | 714,285 | $4.80 | $3.43M | 1,571,741 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2023-08-01 | 2023-08-03 | 119,048 | $4.80 | $571.4K | 2,923,110 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2023-05-17 | 2023-05-19 | 15,490 | — | $0 | 15,490 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2023-05-12 | 2023-05-15 | 228,702 | $6.25 | $1.43M | 3,661,518 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2023-05-11 | 2023-05-15 | 219,230 | $6.48 | $1.42M | 3,432,816 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2023-03-29 | 2023-03-30 | 344,592 | $4.54 | $1.56M | 3,213,586 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2023-03-28 | 2023-03-29 | 156,766 | $4.16 | $652.1K | 2,868,994 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2023-03-27 | 2023-03-29 | 51,074 | $3.70 | $189.0K | 2,712,228 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2022-06-10 | 2022-06-14 | 9,367 | — | $0 | 9,367 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2022-05-24 | 2022-05-26 | 13,440 | — | $0 | 13,440 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2022-04-19 | 2022-04-20 | 1,070,000 | $3.69 | $3.95M | 2,661,154 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2022-01-03 | 2022-01-05 | 6,242 | — | $0 | 6,242 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2021-08-02 | 2021-08-04 | 576,923 | $13.00 | $7.50M | 2,267,411 | SEC↗ |
| RLYB Rallybio Corp | J Other deriv | 2021-07-28 | 2021-08-04 | 10,789,193 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | A Award deriv | 2021-07-28 | 2021-08-04 | 13,440 | — | $0 | 13,440 | SEC↗ |
| RLYB Rallybio Corp | J Other | 2021-07-28 | 2021-08-04 | 1,694,388 | — | $0 | 1,694,388 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2021-06-23 | 2021-06-24 | 9,367 | — | $0 | 9,367 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2021-06-02 | 2021-06-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-10 | 2021-02-10 | 6,632 | $28.66 | $190.1K | 1,405,418 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-10 | 2021-02-10 | 7,567 | $27.64 | $209.2K | 1,412,050 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-10 | 2021-02-10 | 26,688 | $26.78 | $714.7K | 1,419,617 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-10 | 2021-02-10 | 37,271 | $25.75 | $959.7K | 1,446,305 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-09 | 2021-02-10 | 38,248 | $27.12 | $1.04M | 1,666,072 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-09 | 2021-02-10 | 93,740 | $28.75 | $2.70M | 1,483,576 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-09 | 2021-02-10 | 88,756 | $28.07 | $2.49M | 1,577,316 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-08 | 2021-02-10 | 28,922 | $26.06 | $753.7K | 1,704,320 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-08 | 2021-02-10 | 50,874 | $25.64 | $1.30M | 1,733,242 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-03 | 2021-02-04 | 2,768 | $25.06 | $69.4K | 1,784,116 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-02-02 | 2021-02-04 | 14,234 | $25.13 | $357.7K | 1,786,884 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-28 | 2021-02-02 | 2,000 | $25.07 | $50.1K | 1,801,118 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-27 | 2021-01-27 | 2,140 | $25.30 | $54.1K | 1,803,118 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-26 | 2021-01-27 | 16,769 | $25.23 | $423.1K | 1,806,631 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-26 | 2021-01-27 | 1,373 | $26.13 | $35.9K | 1,805,258 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-25 | 2021-01-27 | 15,461 | $26.07 | $403.1K | 1,823,400 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-25 | 2021-01-27 | 19,511 | $25.61 | $499.7K | 1,838,861 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-22 | 2021-01-22 | 11,383 | $25.16 | $286.4K | 1,858,372 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-21 | 2021-01-22 | 100 | $25.11 | $2.5K | 1,869,755 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-20 | 2021-01-22 | 19,046 | $25.35 | $482.8K | 1,869,855 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-19 | 2021-01-19 | 7,000 | $26.05 | $182.3K | 1,888,901 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-19 | 2021-01-19 | 42,516 | $25.55 | $1.09M | 1,895,901 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-15 | 2021-01-19 | 3,808 | $26.05 | $99.2K | 1,938,417 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-15 | 2021-01-19 | 22,869 | $25.74 | $588.6K | 1,942,225 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-14 | 2021-01-19 | 14,918 | $25.88 | $386.1K | 1,965,094 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-13 | 2021-01-13 | 26,010 | $25.90 | $673.7K | 1,983,112 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-13 | 2021-01-13 | 3,100 | $26.34 | $81.7K | 1,980,012 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-12 | 2021-01-13 | 17,666 | $26.35 | $465.5K | 2,010,023 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-12 | 2021-01-13 | 901 | $27.05 | $24.4K | 2,009,122 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-11 | 2021-01-13 | 12,206 | $27.02 | $329.8K | 2,027,689 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-11 | 2021-01-13 | 24,980 | $26.69 | $666.7K | 2,039,895 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-11 | 2021-01-13 | 12,480 | $25.42 | $317.2K | 2,064,875 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-08 | 2021-01-08 | 200 | $28.23 | $5.6K | 2,077,355 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-08 | 2021-01-08 | 8,944 | $27.08 | $242.2K | 2,077,555 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-08 | 2021-01-08 | 31,468 | $26.43 | $831.7K | 2,086,499 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-07 | 2021-01-08 | 22,587 | $28.80 | $650.5K | 2,118,436 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-07 | 2021-01-08 | 24,524 | $27.75 | $680.5K | 2,141,023 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-07 | 2021-01-08 | 469 | $29.51 | $13.8K | 2,117,967 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-06 | 2021-01-08 | 22,507 | $29.99 | $675.0K | 2,165,547 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2021-01-06 | 2021-01-08 | 34,913 | $29.24 | $1.02M | 2,188,054 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-28 | 10,489,510 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 1,403,654 | — | $0 | 1,403,654 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 187,500 | $16.00 | $3.00M | 1,591,154 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2020-07-23 | 2020-07-24 | 9,367 | — | $0 | 9,367 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 211,237 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 1,692,494 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 226,236 | — | $0 | 0 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion | 2020-06-16 | 2020-06-16 | 226,236 | — | $0 | 1,918,730 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion | 2020-06-16 | 2020-06-16 | 211,237 | — | $0 | 2,129,967 | SEC↗ |
| PCVX Vaxcyte, Inc. | P Buy | 2020-06-16 | 2020-06-16 | 93,000 | $16.00 | $1.49M | 2,222,967 | SEC↗ |
| PCVX Vaxcyte, Inc. | C Conversion | 2020-06-16 | 2020-06-16 | 1,692,494 | — | $0 | 1,692,494 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |